6 On the basis of emerging evidence, SGLT2 inhibitors are now transforming the management of heart failure and CKD in patients with and without T2DM.7, 8, 9 Despite these proven clinical benefits, the mechanisms of benefit from SGLT2 inhibitors have not been fully elucidated
Pagano RE Transport of a Fluorescent Phosphatidylcholine Analog from the Plasma Membrane to the Golgi Apparatus
But they can cause pain, and they may lead to complications
Am J Physiol (Endocrinol Metab) 268:E 949955 Balks HJ, Holst JJ, von zur Mhlen A, Brabant G (1997) Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors
What is Wegovy and How Does It Work Wegovy is semaglutide , a GLP-1 receptor agonist